SalvaRx Group (SALV) Share Price, News & Analysis

Company Overview

SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 50,758 shs
• Average Volume: 50,758 shs
• Market Capitalization: £1.65 million
• P/E Ratio: 0.03
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: LON:SALV
• Previous Symbol: LON:3LEG
• CIK: N/A
• Web: www.salvarx.io
• Phone: +44-1624-811611
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.03
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 14.50
• Current Ratio: 1.89
• Quick Ratio: 1.89

Sales & Book Value

• Annual Sales: £64.50 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.50
• Book Value: GBX 15.40 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 36,700,000
• Free Float: N/A
• Market Cap: £1.65 million
• Optionable: Not Optionable
• Beta: N/A